COVID–19 Vaccine Accountability Act

Bill: 117-hr-6282
Sponsor: full_name: Rep. Perry, Scott [R-PA-10]
Introduced: 2021-12-14
Policy area: Health
Subjects: Cardiovascular and respiratory health

Civil actions and liability

Emergency medical services and trauma care

Government liability

Immunology and vaccination

Infectious and parasitic diseases

Manufacturing
Latest action: action_date: 2021-12-15
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2021-12-14
action_desc: Introduced in House
text: <p><strong>COVID-19 Vaccine Accountability Act</strong></p> <p>This bill excludes manufacturers of a mandated COVID-19 vaccine from certain liability protections that apply to manufacturers of medical countermeasures (i.e., medical products that may be used to treat, prevent, or diagnose conditions associated with emerging infectious diseases or chemical, biological, radiological, or nuclear agents). It also retroactively limits to $10,000 the liability of the United States for a death or injury caused by a COVID-19 vaccine administered on or after January 1, 2020.</p>

tv_txt: I 117th CONGRESS 1st Session H. R. 6282 IN THE HOUSE OF REPRESENTATIVES December 14, 2021 Mr. Perry (for himself and Mr. Gohmert ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend title III of the Public Health Service Act to eliminate immunity for manufacturers of COVID–19 vaccines, and for other purposes.

1. Short title This Act may be cited as the COVID–19 Vaccine Accountability Act . 2. Liability of COVID–19 vaccine manufacturers (a) Covered countermeasure Section 319F–3(i)(1) of the Public Health Service Act (42 U.S.C. 247d–6d(i)(1)) is amended by adding at the end the following: Such term does not include vaccines for COVID–19 that are required (directly or as a condition of employment, schooling, or otherwise) under Federal, State, or local law to be administered to individuals eligible to receive such a vaccine. . (b) Covered person Section 319F–3(i)(2) of the Public Health Service Act (42 U.S.C. 247d–6d(i)(2)) is amended by adding at the end the following: Such term does not include a manufacturer of a vaccine described in the matter following subparagraph (D) of paragraph (1). . (c) Limitation of liability Section 319F–3 of the Public Health Service Act ( 42 U.S.C. 247d–6d ) is amended by adding at the end the following: (j) Limitation on liability Pursuant to, and consistent with, the sovereign immunity reservation specified in subsection (f), the liability of the United States for a death or injury caused by the administration of a vaccine for COVID–19 occurring on or after January 1, 2020 shall not exceed $10,000. .